Cyclic Dinucleotides Trigger ULK1 (ATG1) Phosphorylation of STING to Prevent Sustained Innate Immune Signaling  Hiroyasu Konno, Keiko Konno, Glen N. Barber 

Slides:



Advertisements
Similar presentations
STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways  Ji-Ae Kim, Seul-Ki Park, Seong-Wook.
Advertisements

Volume 35, Issue 4, Pages (August 2009)
Volume 15, Issue 2, Pages (February 2014)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 25, Issue 6, Pages (December 2006)
Volume 21, Issue 2, Pages (February 2017)
Volume 33, Issue 2, Pages (January 2009)
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3  Rashu B. Seth, Lijun Sun, Chee-Kwee.
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 24, Issue 5, Pages (May 2006)
STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways  Ji-Ae Kim, Seul-Ki Park, Seong-Wook.
Volume 30, Issue 3, Pages (March 2009)
Volume 22, Issue 5, Pages (May 2012)
Volume 15, Issue 6, Pages (September 2004)
Volume 71, Issue 5, Pages e5 (September 2018)
A Rac-cGMP Signaling Pathway
Volume 19, Issue 6, Pages (September 2005)
Volume 20, Issue 4, Pages (October 2016)
Volume 8, Issue 6, Pages (December 2010)
Volume 68, Issue 2, Pages e6 (October 2017)
Volume 18, Issue 2, Pages (August 2015)
Volume 64, Issue 1, Pages (October 2016)
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Alex M. Agelidis, Satvik R. Hadigal, Dinesh Jaishankar, Deepak Shukla 
Volume 20, Issue 3, Pages (September 2016)
Volume 64, Issue 2, Pages (October 2016)
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Yutian Peng, Lois S. Weisman  Developmental Cell 
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 34, Issue 4, Pages (May 2009)
Volume 37, Issue 6, Pages (December 2012)
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 45, Issue 6, Pages (March 2012)
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
Volume 47, Issue 4, Pages (August 2012)
Volume 12, Issue 2, Pages (August 2012)
Septins Regulate Actin Organization and Cell-Cycle Arrest through Nuclear Accumulation of NCK Mediated by SOCS7  Brandon E. Kremer, Laura A. Adang, Ian.
Volume 3, Issue 2, Pages (February 2006)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 30, Issue 3, Pages (March 2009)
Volume 35, Issue 6, Pages (September 2009)
Volume 26, Issue 6, Pages (June 2007)
Volume 9, Issue 4, Pages (April 2011)
Akt Kinase-Mediated Checkpoint of cGAS DNA Sensing Pathway
Volume 21, Issue 6, Pages (November 2017)
Volume 23, Issue 4, Pages (April 2018)
Volume 25, Issue 5, Pages (March 2007)
Volume 52, Issue 2, Pages (October 2013)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 20, Issue 12, Pages (September 2017)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Identification of Aneuploidy-Selective Antiproliferation Compounds
Volume 33, Issue 5, Pages (November 2010)
Volume 68, Issue 2, Pages e4 (October 2017)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Volume 34, Issue 5, Pages (June 2009)
Volume 28, Issue 5, Pages (May 2008)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 16, Issue 5, Pages (May 2009)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 14, Issue 2, Pages (August 2013)
Volume 14, Issue 1, Pages (July 2013)
Volume 57, Issue 2, Pages (January 2015)
Volume 129, Issue 5, Pages (June 2007)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 38, Issue 3, Pages (March 2013)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Presentation transcript:

Cyclic Dinucleotides Trigger ULK1 (ATG1) Phosphorylation of STING to Prevent Sustained Innate Immune Signaling  Hiroyasu Konno, Keiko Konno, Glen N. Barber  Cell  Volume 155, Issue 3, Pages 688-698 (October 2013) DOI: 10.1016/j.cell.2013.09.049 Copyright © 2013 Elsevier Inc. Terms and Conditions

Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Phosphorylation of STING S366 Inhibits Type I IFN Production in dsDNA Signaling (A) hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) or poly I:C (4 μg/ml) using lipofectamine 2000 for 16 hr. IFNβ level was measured by ELISA. (B) hTERT-BJ1 cells were transfected with dsDNA or poly I:C as described in Figure 1A for the indicated times, and STING was detected by immunoblot. (C and D) hTERT-BJ1 cells were incubated with ethanol (vehicle) or BFA (0.05 μg/ml) for 1 hr and then transfected with dsDNA (4 μg/ml) for the indicated times (C) or 6 hr (D). Immunoblot (C) or immunostaining (D) was performed with the indicated antibodies; lack of LC3 processing (bottom band) indicated loss of autophagy. (E) hTERT-BJ1 cells were treated with siRNA (NS, nonspecific siRNA) for 3 days and then transfected with dsDNA (4 μg/ml) for 6 hr. Immunostaining was performed with the indicated antibodies. (F) Immunoblot was performed to confirm knockdown efficiency of ULK1 and VPS34. (G) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) for 16 hr, and IFNβ was measured by ELISA. (H) Alignment of STING amino acid sequences. Highlighted amino acids indicate dsDNA-dependent phosphorylated serines, as detected by mass spectrometry. (I) Primary Sting−/− MEF cells were reconstituted with STING variants using retroviruses. The cells were transfected with dsDNA (4 μg/ml) or poly I:C (4 μg/ml) for 16 hr, and IFNβ was measured by ELISA. (J) hTERT-BJ1 cells were transfected with HA-tagged mutant hSTING for 36 hr and immunostained with the indicated antibodies. Asterisks indicate significant difference (p < 0.05) compared to NS determined by Student’s t test. Error bars indicate SD. See also Figure S1. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Phosphorylation of S366 of STING Inhibits IRF3 Activity, but Not NF-κB Activity (A and B) HEK293T cells were transfected with plasmids encoding the luciferase gene under control of the indicated promoter with STING variants. After 36 hr, luciferase activity was measured. (C) Primary Sting−/− MEF cells were reconstituted with mSTING variants using retroviruses. The cells were transfected with dsDNA (4 μg/ml) for 3 hr and then stained with the indicated antibodies. (D) Reconstituted Sting−/− MEF cells were transfected with dsDNA (4 μg/ml) for the indicated times, and immunoblots were performed. (E) Reconstituted Sting−/− MEF cells were transfected with dsDNA (4 μg/ml) for 3 hr. RNA was purified and examined for gene expression with Illumina Sentrix BeadChip Array (Mouse WG6 version2). Pseudocolors indicate transcript levels below, equal to, or above the mean (green, black, and red, respectively). The scale represents the intensity of gene expression (log10 scale). The results shown here are representative of three independent experiments. (F) Real-time PCR was carried out with the indicated probes to confirm gene array analysis shown in Figure 2E. Total RNA was extracted from reconstituted Sting−/− MEF cells after dsDNA treatment for 3 hr, and then cDNA was synthesized. (G) The expression of NF-κB target genes in Sting−/− MEF with S365D was comparable with that in Sting−/− MEF with mSTING. Promoter sequence of listed genes (−1,000 to +200) was obtained through DBTSS (http://dbtss.hgc.jp) and analyzed by TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) at threshold score 85. The results shown here are the averages of three independent experiments. Asterisks indicate significant difference (p < 0.05) determined by Student’s t test. ns means not significant. Error bars indicate SD. See also Figure S2. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 ULK1 Negatively Regulates IFNβ Production by Phosphorylating STING S366 (A) ELLISGMEK, which includes Ser366, was used as substrate to identify ULK1 and ULK2. (B) Schematic of human ULK1. KD is kinase domain. (C) In vitro kinase assay was performed with recombinant ULK1 protein using recombinant hSTING protein as substrate. The indicated serine sites that were identified by mass spectrometry were substituted with alanine. (D) Recombinant hSTING protein was incubated with recombinant ULK1 in the presence of ATP for 15 min. Phosphorylated STING was analyzed by mass spectrometry. Highlighted amino acid (S366) was identified as the only phosphorylation site. (E and F) Primary MEF cells (E) or hTERT-BJ1 cells (F) were treated with siRNA as indicated (NS, nonspecific siRNA) and then transfected with dsDNA (4 μg/ml) for 16 hr. IFNβ was measured by ELISA. Knockdown efficiency of ULK1 in primary MEF cells was confirmed by immunoblot. (G) siRNA-treated primary MEF cells were infected with HSV-1 (MOI = 0.1) for 24 hr, and then plaque assay was performed. (H) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) for the indicated times, and then immunoblot was performed. Asterisks indicate significant difference (p < 0.05) compared to NS determined by Student’s t test. ns, not significant. Error bars indicate SD. See also Figure S3. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 dsDNA Induces the Dephosphorylation of AMPK T172 and ULK1 S556 (A and B) hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) (A) or infected with HSV-1 γ34.5 (MOI = 10) (B) for the indicated times, and then immunoblot was carried out with the indicated antibodies. (C) HEK293T cells were cotransfected with plasmids encoding luciferase driven by the IFNβ promoter as well as hSTING and ULK1 variants. After 36 hr, luciferase activity was measured. Error bars indicate SD. See also Figure S4. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 LKB1 Phosphorylation of AMPK Is Disrupted by Cytosolic dsDNA (A) hTERT-BJ1 cells were treated with DMSO (vehicle) or compound C (10 μM) for 1 hr prior to dsDNA transfection (4 μg/ml) for the indicated times. Immunoblot was performed with the indicated antibodies. (B) hTERT-BJ1 cells were treated with DMSO or compound C as described in Figure 5A and then transfected with dsDNA (4 μg/ml) for 6 hr. cDNA was synthesized from total RNA, and then real-time PCR was performed with a probe for Ifnb. (C) hTERT-BJ1 cells were treated with siRNA for NS (nonspecific siRNA) or LKB1 and then transfected with dsDNA (4 μg/ml) for the indicated times. Immunoblot was performed with the indicated antibodies. (D) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) for 16 hr. IFNβ was measured by ELISA. (E and F) hTERT-BJ1 cells were treated with compound C as described in Figure 5A (E) or siRNA for LKB1 as described in Figure 5C (F). Confocal analysis of STING trafficking in response to dsDNA (4 μg/ml) was carried out using anti-STING antibody. Asterisks indicate significant difference (p < 0.05) compared to vehicle (B) or NS (D) determined by Student’s t test. Error bars indicate SD. See also Figure S5. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 cGAS Is Required for the Negative Regulation of STING through the AMPK-ULK1 Axis (A and B) hTERT-BJ1 cells were treated with siRNA for NS (nonspecific), STING (A), and cGAS (B) for 3 days and then transfected with dsDNA (4 μg/ml) for the indicated times. Immunoblot was performed with the indicated antibodies. (C) Knockdown efficiency of cGAS in hTERT-BJ1 cells was confirmed by real-time PCR. (D) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA for 6 hr as described in Figure 6A. STING trafficking was observed by confocal microscopy. (E) siRNA-treated hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) for 16 hr. IFNβ was measured by ELISA. Asterisks indicate significant difference (p < 0.05) compared to NS determined by Student’s t test. Error bars indicate SD. See also Figure S6. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 cGAMPs Activate AMPK-ULK1 Control of STING (A) Primary Sting+/+ and Sting−/− MEF cells were transfected with canonical cGAMP (3′ to 5′ cGAMP) (8 μg/ml) using lipofectamine 2000 for the indicated times. Immunoblot was performed with the indicated antibodies. (B) Primary MEF cells were treated with siRNA for NS (nonspecific), STING, or ULK1 for 3 days and then transfected with dsDNA (4 μg/ml), canonical cGAMP (8 μg/ml), or poly I:C (4 μg/ml) as described in Figure 7A for 16 hr. IFNβ was measured by ELISA. (C) Primary Sting+/+ and Sting−/− MEF cells were transfected with noncanonical cGAMP (2′ to 5′ cGAMP) (8 μg/ml) as described in Figure 7A for the indicated times. Western blot was performed with the indicated antibodies. (D) hTERT-BJ1 cells were treated with siRNA for NS or cGAS for 3 days and then transfected with noncanonical cGAMP (8 μg/ml) as described in Figure 7A for the indicated times. Immunoblot was performed with the indicated antibodies. (E) Model of STING activation by cytosolic DNA and subsequent inhibition by ULK1. Asterisks indicate significant difference (p < 0.05) compared to NS determined by Student’s t test. Error bars indicate SD. See also Figure S6. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S1 dsDNA Induces Phosphorylation of STING, Related to Figure 1 (A) hTERT-BJ1 cells were transfected with 4 μg/ml of dsDNA for the indicated times and then endogenous STING was precipitated, then treated with calf intestinal alkaline phosphatase (CIP). (B) hTERT-BJ1 cells were cultured in phosphate-free DMEM for 2 hr and then cultured in presence of 0.2 mCi/ml of 32P-labeled orthophosphate for 1 hr. After that the cells were transfected with dsDNA (4 μg/ml) or poly I:C (4 μg/ml) for the indicated time. Endogenous STING was pulled down by anti-STING antibody and then autoradiography was performed. (C) hTERT-BJ1 cells were treated with BFA for 1 hr before transfection of dsDNA (4 μg/ml) or poly I:C (4 μg/ml). At 16 hr after the transfection, the supernatant was collected and IFNβ level was measured by ELISA. (D) hTERT-BJ1 cells were treated with chloroquine (50 μM) for 1 hr prior to dsDNA transfection. Western blot was performed using STING and LC3 antibodies. (E) hTERT-BJ1 cells were treated with siRNA for Beclin-1 as described in Figure 1E and transfected with dsDNA (4 μg/ml) for 6 hr. Immunostaining was performed with STING antibody and also knockdown efficiency was confirmed by Western blot. (F and G) Endogenous STING protein was precipitated from hTERT-BJ1 cells transfected with dsDNA for 6 hr. Precipitated STING was visualized in the gel with CBB (F) and all the bands including STING were analyzed by mass spectrometry (G). ∗ and ∗∗ mean native STING and phosphorylated STING, respectively. Untreated cells showed no phosphorylated STING. Highlighted amino acids with pink mean identified phosphorylation sites of STING by mass spectrometry. No phosphorylation sites were identified in native STING. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S2 Phosphorylation of STING on S366 Negatively Regulates IFN Production, Related to Figure 2 (A) STING variants used in this study. (B and C) pcDNA3-hSTING plasmid with the indicated mutation was transfected into primary Sting −/− MEF cells (B) or HEK293T (C) cells with plasmid encoding luciferase gene driven under IFNβ promoter. After 36 hr, luciferase activity was measured. (D) Reconstituted Sting−/− MEF cells with mSTING variant (S365A) were transfected with dsDNA (4 μg/ml) for 3 hr. Purified RNA was examined for gene expression as described in Figure 2E. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S3 STING Is Likely Not a Substrate for TBK1, Related to Figure 3 (A) Primary MEF cells and immortalized Tbk1−/− MEF cells were transfected with dsDNA (4 μg/ml) for the indicated times. Western blot was performed using STING and TBK1 antibodies. (B) Purified TBK1 protein was mixed with purified STING protein or STING variant proteins in presence of [γ-32P] ATP. After the reaction samples were boiled in SDS-sample buffer and then analyzed by gel electrophoresis followed by autoradiography. (C) Purified TBK1 protein was mixed with purified STING protein and then analyzed by mass spectrometry as described in Figure 3D. (D) HEK293T cells were transfected with plasmid encoding human ULK2 for 36 hr as a positive control for Western blot. hTERT-BJ1 cells were treated with siRNA, NS (non-specific) or ULK2 for three days. Western blot was performed using ULK1 and ULK2 antibodies. (E) Primary MEF cells or hTERT-BJ1 cells were treated with siRNA, NS or ULK2 for three days and then total RNA was extracted. After cDNA synthesis, qPCR was performed using murine or human ULK2 probe. Gapdh was used for normalization. These results indicate that siRNA for ULK2 used in this study can suppress ULK2 expression. (F) cDNA from hTERT-BJ1 cells or primary human DC (hDC) was examined by qPCR to determine ULK1 and ULK2 expression. (G) Primary MEF was treated with NS, STING, ULK1, ULK2 siRNA, then infected with HSV-1 luc (MOI = 1) and luciferase activity was measured. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S4 RNA Virus Does Not Induce the Dephosphorylation of AMPK T172 and ULK1 S556, Related to Figure 4 (A) hTERT-BJ1 cells were infected with VSV-GFP (MOI = 1) for the indicated times. Western blot was performed with the indicated antibodies. (B) pcDNA3-hSTING plasmid was transfected into HEK293T cells with pcDNA-hULK1 or variant (K46M) as described in Figure S2C. After 36 hr, luciferase activity was measured. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S5 Compound C Inhibits IRF3 Translocation Induced by dsDNA, Related to Figure 5 (A and B) Primary MEF cells were treated with compound C as described in Figure 5A and then transfected with dsDNA (4 μg/ml) for 16 hr (A) or 3 hr (B). In addition, canonical cGAMP (8 μg/ml) and poly I:C (4 μg/ml) treated primary MEF cells were used to measure IFNβ (A). IFNβ level was measured by ELISA (A) or IRF3 translocation was observed by confocal microscope using IRF3 antibody (B). (C) hTERT-BJ1 cells were treated with siRNA for AMPK1 for three days and then transfected with dsDNA (4 μg/ml) for the indicated times. Western blot was performed with the indicated antibodies. (D) hTERT-BJ1 cells were treated with DMSO (Vehicle) or STO-609 (10 μM) for 1 hr prior to transfection of dsDNA (4 μg/ml) for the indicated times. Western blot was performed with the indicated antibodies. (E) hTERT-BJ1 cells were treated with STO-609 as described in Figure S5D and then transfected with dsDNA (4 μg/ml) for 16 hr. IFNβ level was measured by ELISA. (F) hTERT-BJ1 cells were transfected with dsDNA (4 μg/ml) using lipofectamine 2000 or treated with lipofectamine 2000 only for the indicated times. Western blot was performed with the indicated antibodies. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure S6 STING-Mediated Autophagy Is Specific to dsDNA, Related to Figures 6 and 7 (A) hTERT-BJ1 cells were treated with BFA as described in Figure 1C and then transfected with dsDNA (4 μg/ml) for the indicated times. Western blot was performed with the indicated antibodies. (B) Primary Sting+/+ and Sting−/− MEF cells were transduced with retrovirus vector encoding GFP-LC3. These cells were transfected with dsDNA (4 μg/ml) or poly I:C (4 μg/ml) for 3 hr, or treated with rapamycin (0.5 μM) for 3 hr. LC3 puncture structure was observed by confocal microscope. (C) siRNA treated hTERT-BJ1 cells or primary MEF cells were transfected with dsDNA or cGAMP as described in Figure 7 and then immunostaining was performed with the indicated antibodies. (D) Primary MEF cells were treated with the indicated drugs (Okadaic acid: 50 nM, Metformin: 1 mM or 10 mM, Phenformin: 1 mM, Rapamycin: 0.5 μM) for 1 hr prior to dsDNA (4 μg/ml) or poly I:C (4 μg/ml) transfection. After 16 hr, IFNβ level was measured by ELISA. Error bars indicate SD. Cell 2013 155, 688-698DOI: (10.1016/j.cell.2013.09.049) Copyright © 2013 Elsevier Inc. Terms and Conditions